Evidence map›Paper›PMID 32304242›Full record

ArticleMuscle & nerve2020

Histone acetyltransferase inhibition rescues differentiation of emerin-deficient myogenic progenitors.

Katherine A Bossone, Joseph A Ellis, James M Holaska

Open access · greenAbstract read
In one paragraph

Article in Muscle & nerve, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. The role of inner nuclear membrane protein emerin in myogenesis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. An Omics View of Emery-Dreifuss Muscular Dystrophy.Journal of personalized medicine · 2020
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Katherine A BossoneDepartment of Biomedical Sciences, Cooper Medical School of Rowan University, Camden, New Jersey, United States.ORCID 0000-0001-6582-7912
Joseph A EllisDepartment of Pharmaceutical Sciences, University of the Sciences, Philadelphia, Pennsylvania, United States.ORCID 0000-0002-3448-8345
James M HolaskaDepartment of Biomedical Sciences, Cooper Medical School of Rowan University, Camden, New Jersey, United States.ORCID 0000-0003-0273-9995
University of the Sciences · US

Funding

Emerin regulation of myogenic differentiation: implications for muscle diseaseR15AR069935 · NIAMS · UNIVERSITY OF THE SCIENCES PHILADELPHIA · PI JAMES Michael HOLASKA · 2016 to 2026
$2.0M
NIAMS NIH HHS R15 AR069935
6 · The paper itself

Abstract

introductionEmery-Dreifuss muscular dystrophy (EDMD) is a disease characterized by skeletal muscle wasting, major tendon contractures, and cardiac conduction defects. Mutations in the gene encoding emerin cause EDMD1. Our previous studies suggested that emerin activation of histone deacetylase 3 (HDAC3) to reduce histone 4-lysine 5 (H4K5) acetylation (ac) is important for myogenic differentiation.

methodsPharmacological inhibitors (Nu9056, L002) of histone acetyltransferases targeting acetylated H4K5 were used to test whether increased acetylated H4K5 was responsible for the impaired differentiation seen in emerin-deficient myogenic progenitors.

resultsNu9056 and L002 rescued impaired differentiation in emerin deficiency. SRT1720, which inhibits the nicotinamide adenine dinucleotide (NAD) DISCUSSION: We conclude that emerin regulation of HDAC3 activity to affect H4K5 acetylation dynamics is important for myogenic differentiation. Targeting H4K5ac dynamics represents a potential new strategy for ameliorating the skeletal muscle wasting seen in EDMD1.

Indexed as

AnimalsCell DifferentiationCells, CulturedHistone AcetyltransferasesMiceMice, Inbred C57BLMice, KnockoutMuscular Dystrophy, Emery-DreifussStem CellsThiazoles1,2-bis(isothiazol-5-yl)disulfaneHistone AcetyltransferasesThiazolescell signalingemerinEmery-Dreifuss muscular dystrophymyogenic differentiation

Identifiers

PMID32304242
PMCPMC7382944
OpenAlexW3016950488

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.